Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
2025 · Blood Cancer Journal · 6 citations
https://doi.org/10.1038/s41408-025-01222-y
J
Jordan Snyder
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
297
Citations
7
h-index
6
i10-index
Jordan Snyder is an academic researcher from University of Kansas Medical Center. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & CAR-T cell therapy research & Protein Degradation and Inhibitors. The author has an h-index of 7, co-authored 52 publications.
ORCID: 0000-0002-1001-134XPapers by this author
worksTalquetamab in heavily pretreated patients with multiple myeloma, including BCMA-refractory
2025 · Blood Immunology & Cellular Therapy · 5 citations
https://doi.org/10.1016/j.bict.2025.100001
Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy
2024 · Cureus · 0 citations
https://doi.org/10.7759/cureus.70450
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat